Publication Name	World Journal of Experimental Medicine
Manuscript ID	107020
Country	Lebanon

Category	Endocrinology & Metabolism
Manuscript Type	Minireviews
Article Title	Glucagon like peptide and its receptor agonists in the treatment of rheumatic diseases
Manuscript Source	Unsolicited Manuscript
All Author List	Elie Chamchoum, Nadia Katrib, Nicolas Nassif, Yara Ratel and Mohamad Ali Rida
Funding Agency and Grant Number
Corresponding Author	Mohamad Ali Rida, Assistant Professor, MD, Department of Internal Medicine, Clemenceau Medical Center, Clemenceau, Beirut 1, Lebanon. mohamad.ali.rida@gmail.com
Key Words	Glucagon-like peptide-1 agonists; Osteoarthritis; Rheumatoid arthritis; Psoriatic arthritis; System lupus erythematosus; Inflammation
Core Tip	Growing evidence suggests that glucagon-like peptide-1 and its receptor agonists could be an effective treatment option not only for metabolic disorders but also for a range of autoimmune and inflammatory diseases. They may protect cartilage and reduce joint inflammation, lower the levels of inflammatory cytokines, helping prevent further joint damage and address both the metabolic and inflammatory aspects, reducing cytokine levels and potentially improving disease outcomes.
Citation	Chamchoum E, Katrib N, Nassif N, Ratel Y, Rida MA. Glucagon like peptide and its receptor agonists in the treatment of rheumatic diseases. World J Exp Med 2025; In press

Received	2025-03-13 12:51
Peer-Review Started	2025-03-19 00:16
To Make the First Decision
Return for Revision	2025-04-27 05:09
Revised	2025-05-10 16:34
Second Decision	2025-07-10 02:46
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-07-10 09:19
Articles in Press	2025-07-10 09:19
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	2220-315x (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com